Competitor weight loss pills gain 15% market share in UK by 2027-03-31

By March 31, 2027, competitor weight loss pills (e.g., Zepbound, Mounjaro, or new entrants) will capture at least 15% of the UK prescription weight loss pill market, eroding Wegovy’s early lead. This shift will be driven by pricing strategies, formulary inclusion by private insurers, and patient preference for oral alternatives.

adoption · Prediction Market

Implied probability (Yes)

70%

Closes

2027-03-31

More adoption markets

• OpenAI Codex mobile usage exceeds desktop by Q1 2027 — 72% Yes
• OpenAI Codex mobile usage surpasses desktop within 6 months — 70% Yes
• Major tech companies to mandate AI voice tools in offices by 2027 — 70% Yes
• Animal rights NGOs expand operations in Uganda by 2027 — 75% Yes
• Elliott Management opens new China-focused fund within 9 months — 55% Yes
• Decline in assets under management for single-stock leveraged ETFs by 2027-06-30 — 60% Yes
• Canvas adoption declines by 5% among K-12 schools in 2026 — 70% Yes
• Anthropic's enterprise AI share surpasses 30% by Q4 2026 — 75% Yes

Browse all adoption markets →